University of South Carolina
sc.eduTotal trials
189
Active
48
Phase 3
4
Total enrollment
55,497
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Teriparatide | — | — | — | — | — | 1 | |
| Placebos | — | — | — | — | — | 1 | |
| GLP-1 Therapy | — | — | — | — | — | 1 |
Next readouts
- 2026-11-01
- 2026-12-30
Top conditions
- Obesity25
- Physical Activity16
- Stroke9
- Overweight and Obesity7
- Healthy7
- Overweight7
- Breast Cancer6
- Sleep5
Frequently asked questions about University of South Carolina
- How many clinical trials does University of South Carolina have on ClinicalTrials.gov?
- University of South Carolina is listed as the lead sponsor on 189 clinical trials in ClinicalTrials.gov, 48 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of South Carolina's trials are in Phase 3?
- 4 of University of South Carolina's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does University of South Carolina focus on?
- University of South Carolina's most-studied conditions on ClinicalTrials.gov are Obesity, Physical Activity, Stroke, Overweight and Obesity, Healthy.
- When are University of South Carolina's next clinical trial readouts?
- University of South Carolina has 2 upcoming primary-completion readouts tracked here; the soonest is “Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy”, expected around 2026-11-01.